Recently, the role of IL-20 cytokine subfamily has been proposed in tissue remodeling [26], and increased expression of IL-19, -20 and -24 was demonstrated in PBMCs and also in colonic mucosa of adult IBD patients [11, 13–15]. This evidence concerns the gene IL20 and inflammatory bowel disease.